The registered shares of Actelion Ltd were first listed on the SWX New Market on April 6, 2000 (symbol: ATLN). A total of 1,000,000 primary shares were placed at the company’s Initial Public Offering (IPO), at a price of CHF 260 per share, raising CHF 246.6 million.
On 22 November 2006, Actelion Finance SCA, Luxembourg issued CHF 460 million of senior convertible bonds due 2011 unconditionally and irrevocably guaranteed by Actelion Ltd, Allschwil, Switzerland. The bonds have a coupon of zero percent and an annual yield to maturity of zero percent. The conversion price is CHF 54.17. On or after 30 June 2007 and until the 30th trading day prior to the maturity date on 22 November 2011, each Bond in the denomination of CHF 5,000 is convertible free of charge into cash up to the principal amount and any conversion value above the principal amount may be settled, at the option of Actelion, into cash or Shares or a combination thereof. The issue price was set at 100% and the redemption price at 100%. The Bonds are non-callable for life.
On 18 January 2007, Actelion exercised its right to call for an early redemption of the Senior Unsecured Zero Coupon Convertible Bonds due 15 October 2008 issued by Actelion Finance SCA, Luxembourg on 1 October 2003. The redemption date was 19 February 2007. The bonds were fully converted and 937.068 shares were issued.
On 8 July 2008, the Management Committee of the SIX Swiss Exchange decided to add Actelion shares (ATLN, CH0010532478) to the Swiss Market Index SMI®. Actelion shares have traded as part of the SMI since 22nd September 2008.
Actelion Ltd is part of the following indices: SMI, SPI, SLI, SPIMLC, SPI20, SPISMC, SXXP, SXDP, SBC100, SNSPIX, SMHCAX, SLDI, SXI LIFE SCIENCES and SXI Bio+Medtech. Actelion is traded under the following symbols: Reuters: ATLN.S/ Bloomberg ATLN.
| Key share data | |
| Shares outstanding as of 30.06.2010 | 129.3 million |
| Closing share price as of 30.06.2010 | CHF 40.50 |
| Market capitalization as of 30.06.2010 | CHF 5.2 billion |
| 52-week high | CHF 65.10 |
| 52-week low | CHF 40.00 |
| YTD price change | -29 % |
| Average daily volume | 0.7 million |
| Free float | 92.03% |
| Shareholdings as of 30.06.2010 | |
| Number of registered shareholders | 11,711 |
| Major shareholders as per 30.06.2010 | |
| Management and Directors | > 5% |
| BB Biotech | > 5% |
| Actelion Ltd | > 5% |
| Rudolf Maag | > 3% |
This content is updated on a quarterly basis.
